National Heart, Lung, and Blood Institute

US-NIH-NHLBI-Logo

National Heart, Lung, and Blood Institute (NHLBI) is a division of the National Institutes of Health (NIH), which is itself a part of the United States Department of Health and Human Services (HHS). The NHLBI is primarily responsible for conducting and supporting research into the causes, treatment, and prevention of heart, lung, and blood diseases. It aims to improve the health of all Americans by providing leadership and support for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases.

History

The National Heart, Lung, and Blood Institute was established in 1948 as the National Heart Institute. The institute expanded its mandate to include blood diseases in 1969 and lung diseases in 1972, at which point it adopted its current name. Since its inception, the NHLBI has been at the forefront of medical research in its fields, contributing to significant advancements in the understanding and treatment of heart, lung, and blood diseases.

Research and Funding

The NHLBI supports a wide range of research from basic science to clinical trials and population studies. It funds research conducted in its own laboratories and by scientists in universities and research institutions across the country through grants and contracts. The institute also supports training and career development for researchers at various stages of their careers.

Key research areas include:

• Cardiovascular diseases: Research aimed at understanding, preventing, and treating conditions such as coronary artery disease, hypertension, and heart failure.
• Lung diseases: Including research on asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and sleep apnea.
• Blood diseases: Research on conditions such as anemia, sickle cell disease, and hemophilia.
• Sleep disorders: Investigating the impact of sleep on health and disease.

Programs and Initiatives

The NHLBI oversees several key programs and initiatives to advance its mission, including:

• The Framingham Heart Study, a long-term, ongoing cardiovascular cohort study on residents of Framingham, Massachusetts. The study has contributed significantly to the understanding of heart disease risk factors.
• The National Asthma Education and Prevention Program (NAEPP), which aims to improve the quality of life for individuals with asthma through education and prevention.
• The Women's Health Initiative (WHI), a long-term national health study focused on strategies for preventing heart disease, breast and colorectal cancer, and osteoporosis in postmenopausal women.

Education and Outreach

The NHLBI also engages in extensive education and outreach efforts aimed at the public and healthcare professionals. These efforts include the development and dissemination of educational materials and guidelines for the prevention and management of heart, lung, and blood diseases.

See Also

• Heart disease
• Lung cancer
• Blood transfusion
• Sleep medicine

External Links

Given the constraints, external links cannot be provided.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian